Securian Asset Management’s Cytokinetics CYTK Stock Holding History

Securian Asset Management’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$803K	Buy	10,012 +1,000	+11%	+$71.8K	0.03%	440
2026 Q1	$594K	Buy	9,012 +102	+1%	+$6.48K	0.02%	531
2025 Q4	$566K	Sell	8,910 -51	-0.6%	-$3.17K	0.02%	553
2025 Q3	$492K	Sell	8,961 -134	-1%	-$5.52K	0.01%	693
2025 Q2	$300K	Buy	9,095 +174	+2%	+$6.05K	0.01%	838
2025 Q1	$359K	Hold	8,921	–	–	0.01%	794
2024 Q4	$420K	Sell	8,921 -223	-2%	-$11.6K	0.01%	755
2024 Q3	$483K	Hold	9,144	–	–	0.01%	721
2024 Q2	$495K	Buy	9,144 +1,081	+13%	+$65.3K	0.01%	684
2024 Q1	$565K	Buy	+8,063	New	+$624K	0.02%	662

Other funds holding CYTK

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Securian Asset Management's CYTK Position: Q2 2026 in Review

Securian Asset Management increased its Cytokinetics (CYTK) stake by 11% in Q2 2026, buying an estimated $71.8K and bringing the position to 10,012 shares worth $803K. The position accounts for 0.03% of the portfolio, ranked #440.

Securian Asset Management first reported a position in CYTK in Q1 2024 and has held it in 10 quarters since. 53 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

Securian Asset Management held 10,012 shares of Cytokinetics worth $803K as of Q2 2026.
Securian Asset Management bought 1,000 Cytokinetics shares in Q2 2026, an estimated $71.8K.
Cytokinetics made up 0.03% of Securian Asset Management's portfolio in Q2 2026, its #440 holding.
Securian Asset Management first reported a position in Cytokinetics in Q1 2024 and has held it in 10 quarters since.
53 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Securian Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.